UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

What have we learned about how to prevent and treat antibody‐mediated rejection in kidney transplantation?

American journal of transplantation, 2020-06, Vol.20 (S4), p.12-22

Nickerson, Peter W.

2020

Volltextzugriff (PDF)

Rationale for the IMAGINE study for chronic active antibody‐mediated rejection (caAMR) in kidney transplantation

American journal of transplantation, 2022-12, Vol.22 (S4), p.38-44

Nickerson, Peter W.

2022

Volltextzugriff (PDF)

Understanding Medication Nonadherence after Kidney Transplant

Journal of the American Society of Nephrology, 2017-08, Vol.28 (8), p.2290-2301

2017

Volltextzugriff (PDF)

HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity

American journal of transplantation, 2019-06, Vol.19 (6), p.1708-1719

2019

Volltextzugriff (PDF)

Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development

Journal of the American Society of Nephrology, 2017-11, Vol.28 (11), p.3353-3362

2017

Volltextzugriff (PDF)

HLA class I peptide polymorphisms contribute to class II DQβ0603:DQα0103 antibody specificity

Nature communications, 2024-01, Vol.15 (1), p.609-609, Article 609

2024

Volltextzugriff (PDF)

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design

Trials, 2022-12, Vol.23 (1), p.1042-1042, Article 1042

2022

Volltextzugriff (PDF)

HLA-DR/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens

Frontiers in genetics, 2024-08, Vol.15, p.1447141

2024

Volltextzugriff (PDF)

Serum Creatinine Measurement Immediately After Cardiac Surgery and Prediction of Acute Kidney Injury

American journal of kidney diseases, 2012-02, Vol.59 (2), p.196-201

2012

Volltextzugriff (PDF)

Molecular Mismatch and the Risk for T Cell–Mediated Rejection

American journal of kidney diseases, 2022-12, Vol.80 (6), p.704-706

2022

Volltextzugriff (PDF)

Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohort

PloS one, 2012-07, Vol.7 (7), p.e40692-e40692

2012

Volltextzugriff (PDF)

Urinary Hepcidin-25 and Risk of Acute Kidney Injury Following Cardiopulmonary Bypass

Clinical journal of the American Society of Nephrology, 2011-10, Vol.6 (10), p.2340-2346

2011

Volltextzugriff (PDF)

Molecular Mismatch-the Renaissance of HLA in Kidney Transplantation

Journal of the American Society of Nephrology, 2020-09, Vol.31 (9), p.1922-1925

2020

Volltextzugriff (PDF)

Role of HLA molecular mismatch in clinical practice

Human immunology, 2022-03, Vol.83 (3), p.219-224

2022

Volltextzugriff (PDF)

Immune Monitoring of Kidney Allografts

American journal of kidney diseases, 2012-10, Vol.60 (4), p.629-640

2012

Volltextzugriff (PDF)

More precise donor–recipient matching: the role of eplet matching

Current opinion in nephrology and hypertension, 2020-11, Vol.29 (6), p.630-635

2020

Volltextzugriff (PDF)

The negative impact of T cell–mediated rejection on renal allograft survival in the modern era

American journal of transplantation, 2022-03, Vol.22 (3), p.761-771

2022

Volltextzugriff (PDF)

Functional Gene Polymorphisms in Canadian Aboriginal Populations with High Rates of Tuberculosis

The Journal of infectious diseases, 2008-10, Vol.198 (8), p.1175-1179

2008

Volltextzugriff (PDF)

Human leukocyte antigen molecular mismatch to risk stratify kidney transplant recipients

Current opinion in organ transplantation, 2020-02, Vol.25 (1), p.8-14

2020

Volltextzugriff (PDF)

A call to action—The transplant recipient's expectation of precision in transplant medicine

American journal of transplantation, 2018-12, Vol.18 (12), p.2845-2846

2018

Volltextzugriff (PDF)

Identification of Antibodies to DQβ:DRα Interisotypic Heterodimers in Human Sera

Transplantation, 2024-05, Vol.108 (5), p.1142

2024

Volltextzugriff (PDF)

Evidence for the alloimmune basis and prognostic significance of Borderline T cell–mediated rejection

American journal of transplantation, 2020-09, Vol.20 (9), p.2499-2508

2020

Volltextzugriff (PDF)

A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression

American journal of transplantation, 2023-12, Vol.23 (12), p.1882-1892

2023

Volltextzugriff (PDF)

Safety and efficacy of a reduced frequency viral monitoring strategy for Epstein‐Barr virus, cytomegalovirus, and BK polyomavirus post‐kidney transplant: A quality assurance initiative

Clinical transplantation, 2024-04, Vol.38 (4), p.e15292-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(124)

Publikationsform

Artikel
(170)
Bücher
(2)

Sprache

Englisch
(172)

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(130)
Humans
(104)
Female
(61)
Male
(59)
Transplantation
(52)
Surgery
(41)
Immunology
(35)
Middle Aged
(33)
Adult
(32)
Kidney Transplantation
(32)
Biological And Medical Sciences
(29)
Medical Sciences
(27)
Animals
(23)
Risk Factors
(23)
Kidney Transplantation - Adverse Effects
(22)
Graft Rejection
(20)
Graft Survival
(17)
Aged
(16)
Genetics & Heredity
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

What have we learned about how to prevent and treat antibody‐mediated rejection in kidney transplantation?

Rationale for the IMAGINE study for chronic active antibody‐mediated rejection (caAMR) in kidney transplantation

Understanding Medication Nonadherence after Kidney Transplant

HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity

Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development

HLA class I peptide polymorphisms contribute to class II DQβ0603:DQα0103 antibody specificity

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design

HLA-DR/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens

Serum Creatinine Measurement Immediately After Cardiac Surgery and Prediction of Acute Kidney Injury

Molecular Mismatch and the Risk for T Cell–Mediated Rejection

Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohort

Urinary Hepcidin-25 and Risk of Acute Kidney Injury Following Cardiopulmonary Bypass

Molecular Mismatch-the Renaissance of HLA in Kidney Transplantation

Role of HLA molecular mismatch in clinical practice

Immune Monitoring of Kidney Allografts

More precise donor–recipient matching: the role of eplet matching

The negative impact of T cell–mediated rejection on renal allograft survival in the modern era

Functional Gene Polymorphisms in Canadian Aboriginal Populations with High Rates of Tuberculosis

Human leukocyte antigen molecular mismatch to risk stratify kidney transplant recipients

A call to action—The transplant recipient's expectation of precision in transplant medicine

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation

Identification of Antibodies to DQβ:DRα Interisotypic Heterodimers in Human Sera

Evidence for the alloimmune basis and prognostic significance of Borderline T cell–mediated rejection

A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression

Safety and efficacy of a reduced frequency viral monitoring strategy for Epstein‐Barr virus, cytomegalovirus, and BK polyomavirus post‐kidney transplant: A quality assurance initiative

Suchergebnisse filtern